- Report
- September 2026
- 198 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- August 2026
- 160 Pages
Global
From €2994EUR$3,320USD£2,568GBP
€3743EUR$4,150USD£3,209GBP
- Report
- October 2025
- 160 Pages
Global
From €2850EUR$3,160USD£2,444GBP
€3562EUR$3,950USD£3,055GBP
- Report
- January 2026
- 545 Pages
Global
From €4464EUR$4,950USD£3,828GBP
- Report
- September 2026
- 192 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- September 2026
- 462 Pages
Global
From €5276EUR$5,850USD£4,524GBP
- Report
- July 2026
- 150 Pages
Global
From €3382EUR$3,750USD£2,900GBP
- Report
- June 2026
- 120 Pages
Global
From €4284EUR$4,750USD£3,673GBP
- Report
- January 2025
- 152 Pages
Global
From €2029EUR$2,250USD£1,740GBP
- Report
- January 2024
- 492 Pages
Global
From €4194EUR$4,650USD£3,596GBP
- Report
- October 2023
- 154 Pages
Global
From €4194EUR$4,650USD£3,596GBP
- Report
- February 2025
- 169 Pages
Latin America
From €7666EUR$8,500USD£6,573GBP
- Report
- June 2022
- 257 Pages
Global
From €2367EUR$2,625USD£2,030GBP
€4735EUR$5,250USD£4,060GBP
- Report
- July 2025
- 125 Pages
Global
From €5366EUR$5,950USD£4,601GBP
- Report
- October 2024
- 90 Pages
United States
From €5366EUR$5,950USD£4,601GBP
- Report
- September 2025
- 150 Pages
United States
From €5366EUR$5,950USD£4,601GBP
- Report
- October 2023
- 120 Pages
India
From €5366EUR$5,950USD£4,601GBP
- Report
- July 2025
- 188 Pages
Global
From €4058EUR$4,500USD£3,480GBP

The Oncology NGS market is a subset of the biotechnology industry that focuses on the development of technologies and products related to the diagnosis and treatment of cancer. This includes the use of next-generation sequencing (NGS) to identify genetic mutations in cancer cells, as well as the development of targeted therapies and immunotherapies to treat cancer. NGS is a powerful tool for cancer research, as it can provide a comprehensive view of the genetic makeup of a tumor, allowing for more accurate diagnosis and treatment.
The Oncology NGS market is highly competitive, with a number of companies offering products and services related to cancer diagnosis and treatment. These include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and Qiagen. Additionally, there are a number of smaller companies that specialize in specific areas of oncology NGS, such as bioinformatics, data analysis, and drug development. Show Less Read more